From Alphastreet - Earnings Decoded. Market Intelligence Delivered · AlphaStreet Newsdesk · · 30s
AtriCure Q3 2026 Earnings Beat
AtriCure's Q3 2026 earnings beat Wall Street expectations with $0.17 EPS and $154.4M revenue.
In brief
AtriCure's Q3 2026 earnings beat Wall Street expectations with $0.17 EPS and $154.4M revenue. AtriCure exceeded Q3 2026 earnings estimates with $0.17 adjusted EPS and $154.4M revenue. Originally reported by Alphastreet - Earnings Decoded. Market Intelligence Delivered.
Q3 2026 Results
AtriCure delivered adjusted earnings per diluted share of $0.17 against analyst estimates of $0.01.
Revenue Beat
The company reported $154.4M revenue, exceeding consensus estimates of $151.2M by 2.2%.
Net Income
Net income reached $4.1M for Q3 2026, up 15.0% year-over-year from Q3 2025.
At a glance
AtriCure exceeded Q3 2026 earnings estimates with $0.17 adjusted EPS and $154.4M revenue.
